Although remarkable progress has enabled the development of new therapeutic options for people living with multiple sclerosis (MS), continued research is critical to finding a cure as well as more effective and convenient treatments.

Signant’s comprehensive clinical research solutions and services improve MS studies by optimizing endpoint data quality and addressing operational challenges in today’s complex research landscape.

Our solutions help study teams:

• Improve data quality captured from EDSS and other assessments
• Reduce rater inconsistency and unwanted variability
• Minimize burdens on sites and patients
• Conduct multinational research

Learn more by downloading our brochure.